======= BHLHA15 ======= == Gene Information == * **Official Symbol**: BHLHA15 * **Official Name**: basic helix-loop-helix family member a15 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=168620|168620]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7RTS1|Q7RTS1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BHLHA15&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BHLHA15|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608606|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in controlling the transcriptional activity of MYOD1, ensuring that expanding myoblast populations remain undifferentiated. Repression may occur through muscle-specific E- box occupancy by homodimers. May also negatively regulate bHLH- mediated transcription through an N-terminal repressor domain. Serves as a key regulator of acinar cell function, stability, and identity. Also required for normal organelle localization in exocrine cells and for mitochondrial calcium ion transport. May function as a unique regulator of gene expression in several different embryonic and postnatal cell lineages. Binds to the E- box consensus sequence 5'-CANNTG-3' (By similarity). {ECO:0000250|UniProtKB:Q9QYC3}. |HLH| |intracellular distribution of mitochondria| |mitochondrion distribution| |negative regulation of myotube differentiation| |mitochondrial calcium ion transmembrane transport| |negative regulation of striated muscle cell differentiation| |cellular response to glucose starvation| |mitochondrion localization| |negative regulation of muscle cell differentiation| |regulation of myotube differentiation| |regulation of striated muscle cell differentiation| |endoplasmic reticulum unfolded protein response| |cellular response to unfolded protein| |Golgi organization| |calcium-mediated signaling| |cellular response to topologically incorrect protein| |cellular response to starvation| |regulation of muscle cell differentiation| |cell maturation| |response to unfolded protein| |glucose homeostasis| |carbohydrate homeostasis| |response to topologically incorrect protein| |response to starvation| |calcium ion transmembrane transport| |cellular response to nutrient levels| |developmental maturation| |calcium ion transport| |response to endoplasmic reticulum stress| |cellular response to extracellular stimulus| |divalent metal ion transport| |divalent inorganic cation transport| |RNA polymerase II regulatory region sequence-specific DNA binding| |cellular response to external stimulus| |second-messenger-mediated signaling| |endomembrane system organization| |mitochondrion organization| |DNA-binding transcription activator activity, RNA polymerase II-specific| |response to nutrient levels| |response to extracellular stimulus| |inorganic cation transmembrane transport| |organelle localization| |cation transmembrane transport| |metal ion transport| |inorganic ion transmembrane transport| |negative regulation of cell differentiation| |cation transport| |protein homodimerization activity| |negative regulation of developmental process| |ion transmembrane transport| |chemical homeostasis| |cell-cell signaling| |positive regulation of transcription by RNA polymerase II| |transmembrane transport| |G protein-coupled receptor signaling pathway| |ion transport| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |cell development| |intracellular signal transduction| |cellular response to stress| |positive regulation of RNA metabolic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.02| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.82| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|1.82| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10426 * **Expression level (log2 read counts)**: -2.69 {{:chemogenomics:nalm6 dist.png?nolink |}}